Differential effects of the allosteric enhancer (2-amino-4,5-dimethyl-trienyl)[3-(trifluoromethyl) phenyl]methanone (PD81,723) on agonist and antagonist binding and function at the human wild-type and a mutant (T277A) adenosine A1 receptor

This publication has 12 references indexed in Scilit:

• Allosteric Modulation of the Adenosine A₁ Receptor. Synthesis and Biological Evaluation of Novel 2-Amino-3-benzoylthiophenes as Allosteric Enhancers of Agonist Binding
  Journal of Medicinal Chemistry, 1999
• Thermodynamics of full agonist, partial agonist, and antagonist binding to wild-type and mutant adenosine A1 receptors
  Biochemical Pharmacology, 1998
• PD 81,723, an Allosteric Enhancer of the A ₁ Adenosine Receptor, Lowers the Threshold for Ischemic Preconditioning in Dogs
  Circulation Research, 1996
• Conformational induction versus conformational selection: evidence from allosteric enhancers: Allosteric enhancers show that receptor activation proceeds mainly by conformational induction
  Trends in Pharmacological Sciences, 1996
• Identification of Domains of the Human A1 Adenosine Receptor That Are Important for Binding Receptor Subtype-selective Ligands Using Chimeric A1/A2a Adenosine Receptors
  Published by Elsevier ,1995
• The allosteric enhancer, PD 81,723, stabilizes human A1 adenosine receptor coupling to G proteins
  Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1995
• Allosteric enhancer PD 81,723 acts by novel mechanism to potentiate cardiac actions of adenosine.
  Circulation Research, 1994
• Molecular cloning and characterisation of a human brain A1 adenosine receptor cDNA
  Molecular Brain Research, 1992
• Measurement of protein using bicinchoninic acid
  Analytical Biochemistry, 1985
• Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction
  Biochemical Pharmacology, 1973